presentación de powerpoint - eulac permed · 2020. 2. 19. · eulac-permed has been funded by the...
TRANSCRIPT
EULAC-PerMed has been funded by the
European Union’s Horizon 2020
Research and Innovation Programme
under Grant Agreement (GA) No 825173
Esther Rodríguez, PhDHead of European Project OfficeInstituto de Salud Carlos III Montevideo, December 2019
Project Overview
Research on Personalized Medicine (PerMed) is a top priority for the European Union (EU) as a strategy aimed at delivering personalised health and care
solutions to benefit citizens.
Investment & Alignment
• Council conclusions on personalised medicine for patients, published in December 2015.
• International Consortium forPersonalized Medicine (ICPerMed) since Nov. 2016
• ERAPerMed ERANET forPersonalized Medicine sinceDec. 2017
• + several Coordination & Support Actions
EULAC PerMed as part of the ICPerMedFamily
EULAC PerMed
In order to strengthen the global efforts on Personalized Medicine and the cooperation of
Europe (EU) with Latin American and Caribbean (LAC) countries , the EULAC
PerMed project, funded by the Horizon 2020 Programme of the European Commission, has
been launched in January 2019
EULAC PerMed has the ambition to engage LAC countries in the International
Consortium on Personalized Medicine (ICPerMed) and in the
ERANet ERAPerMed with the aim at advancing in the implementation of the
Action Plan of ICPerMed.
SPECIFIC OBJECTIVES
• EULAC PerMed will be the vehicle for:
• Mapping existing programmes, capacities and expertise and gaps in CELAC countries. (WP2)
• Facilitating the incorporation of LAC countries in ICPerMed and in the ERAPerMed. (WP3)
• Fostering the participation of LAC countries in research mobility and transnational projects on PerMed, and a platform for EU‐LAC collaboration on clinical trials PerMed focused. (WP4)
• Cross-border learning from Research and Innovation and the ethical, legal and social aspects for implementing innovations between research capacities based in EU and LAC. (WP5)
ES WP1
PA ES WP2
SGCTeIP AR DE WP3
UY IT WP4
BR EU/FR WP5
CL IL WP6
A birregional Consortium
+Associated Partners
Associated Partner Country
CONACYT - Consejo Nacional de Ciencia y Tecnología Paraguay
MINEDU - Ministerio de Educación Bolivia
LANOTEC-CeNAT - Laboratorio Nacional de Nanotecnología Costa Rica
SENACYT - Secretaría Nacional de Ciencia y Tecnología Guatemala
VTT - Technical Research Centre of Finland Ltd Finland
Ministerio de Salud Panamá
Implementation
EXPECTED IMPACT
Contributing to the success and long-term impact of PerMed
Research activities promoted in the framework of IC PerMed
enabling a wider/international engagement in PM, faster
uptake of results, and alignment and adoption of common
standards in the regions thanks to COOPERATION
http://www.eulac-permed.eu/
@EULACPerMed
https://www.linkedin.com/in/eulac-permed-project/